SPOTLIGHT -
Baltimore-With their excellent therapeutic profiles, the prostaglandin analogues and their related compounds have launched glaucoma treatment into an exciting new era, according to Eve J. Higginbotham, MD.
Bausch + Lomb announces results from a clinical study of a novel daily nutritional supplement for dry eyes
(EyePod) From idea to impact: Navigating ophthalmic innovation
The Fred Hollows Foundation supporting 2030 IN SIGHT LIVE
EyePod: Modifier Gene Therapy: What is it?
Verana Health launches its Qdata Thyroid Eye Disease module
Gene editing untangles one strand of the AMD web